Structure |
Chemical Name |
CAS |
MF |
|
1-((2R,3R)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-(((3-(hydroxymethyl)pyridin-2-yl)(methyl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium chloride |
|
|
|
Amoxicillin Impurity ABCDEFGHIJKLM |
|
|
|
β-D-Glucopyranoside, [[(3R,3aS,6S,6aR)-tetrahydro-3a-hydroxy-1H,3H-furo[3,4-c]furan-3,6-diyl]bis(2-methoxy-4,1-phenylene)]bis |
112747-99-6 |
C32H42O17 |
|
1H-1,2,4-Triazole-1-propanol, α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)- |
1222655-38-0 |
C14H14F2N6O |
|
3-Pyrrolidinepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-, (αS,3S)- |
741267-75-4 |
C12H20N2O5 |
|
Topiroxostat Impurity 44 |
1824131-48-7 |
C7H6N4O |
|
Fexofenadine Impurity 12 |
1010812-98-2 |
C32H37NO4 |
|
2,2'-(oxybis((2-chloro-5-iodophenyl)methylene))diphenol |
|
C26H18Cl2I2O3 |
|
Gliclazide Impurity 6 |
1207714-41-7 |
C8H10N2O3S |
|
Phenol, 4,4'-(4-pyridinylmethylene)bis- |
109810-81-3 |
C18H15NO2 |
|
Ropivacaine Impurity 50 |
|
|
|
Glycine, N-[(4,7-dihydroxy-1-methyl-3-isoquinolinyl)carbonyl]- |
2173338-12-8 |
C13H12N2O5 |
|
5-Thiazolecarboxylic acid, 2-[3,5-diformyl-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester |
2375033-26-2 |
C19H21NO5S |
|
Furosemide Impurity 6 |
74793-12-7 |
C12H10ClNO3 |
|
Lumateperone Impurity 3 |
313544-76-2 |
C17H21N3O3 |
|
Butanoic acid, L-2-aminobutanoyl-L-2-amino-, methyl ester (9CI) |
772292-30-5 |
C9H18N2O3 |
|
Hexanoic acid, 3-(hydroxymethyl)-, (3R)- |
2096999-79-8 |
C7H14O3 |
|
2-(((Z)-(1-(2-aminothiazol-4-yl)-2-(((2S,3S)-1-(ethoxysulfonyl)-2-methyl-4-oxoazetidin-3-yl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoic acid |
|
|
|
3-(4-FLUORO-PHENYL)-1-ISOPROPYL-1H-INDOLE-2-CARBALDEHYDE |
101125-34-2 |
C18H16FNO |
|
3,4-DIMETHOXY-2-HYDROXYBENZALDEHYDE |
19283-70-6 |
C9H10O4 |
|
4-PYRIDIN-4-YL-BUTYRIC ACID |
102878-73-9 |
C9H11NO2 |
|
3-Thiophenecarboxylic acid, 4-formyl-2,5-dihydro-2-(4-hydroxybutylidene)-5-methyl-, (2Z)- |
1025974-23-5 |
C11H14O4S |
|
1H-Pyrrole-3-methanamine, 1-[(1,4-dihydro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)-N-methyl- |
2416241-98-8 |
C17H18FN3O2S |
|
impurity 44 |
|
|
|
3-((2-acetamido-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)propane- 1,2-diyl diacetate |
96429-68-4 |
|
|
L-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, γ-lactone, 3,5-dibenzoate, (2S)- |
1946820-91-2 |
C20H17FO6 |
|
5,5'-Bi-1H-benzimidazole, 6,6'-bis(difluoromethoxy)-2,2'-bis[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]- |
2251784-93-5 |
C32H28F4N6O6S2 |
|
1,4,7,10-Tetraazacyclododecane-1,7-diacetic acid, 4,10-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]- |
2514736-58-2 |
C20H40N4O10 |
|
Valsartan Methyl Ester N2-Trityl Analog |
883223-10-7 |
C44H45N5O3 |
|
Ampicillin Impurity G |
|
|
|
N-(5-((diphenylphosphoryl)methyl)-4-(3-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide |
|
|
|
Azacitidine Impurity EJ |
|
|
|
Budesonide Impurity 28 |
|
|
|
Ethanol, 2-[2-(2-methyl-4-nitro-1H-imidazol-1-yl)ethoxy]- |
19765-12-9 |
C8H13N3O4 |
|
INDEX NAME NOT YET ASSIGNED |
2452301-30-1 |
C23H27ClO7 |
|
(5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((S)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4,4-dioxide |
|
|
|
(3S,5R,6E) Rosuvastatin Calcium Salt (2:1) |
2414245-11-5 |
C22H30CaFN3O6S |
|
INDEX NAME NOT YET ASSIGNED |
2452301-42-5 |
C23H27ClO7 |
|
Avatrombopag Impurity 35 |
|
|
|
2-AMINO-2'-FLUOROBENZOPHENONE |
1581-13-1 |
C13H10FNO |
|
(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium |
2480467-84-1 |
C28H35NO7S |
|
5-METHOXY-2-(METHYLTHIO)BENZIMIDAZOLE |
91168-31-9 |
C9H10N2OS |
|
4-METHYL-6-PYRIDIN-3-YLPYRIMIDIN-2-AMINE |
90916-52-2 |
C10H10N4 |
|
1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylindenemethyl)piperidine |
120014-07-5 |
C24H27NO3 |
|
Crisaborole Impurity 16 |
2268785-42-6 |
C14H10BNO3 |
|
guanidine |
113-00-8 |
CH5N3 |
|
tert-Butyl (E)-3,5-Dihydroxy-7-[3'-(4"-fluorophenyl)-1'-methylethylindol-2'-yl)hept-6-enoate |
194934-96-8 |
C28H34FNO4 |
|
ethyl (R)-thiazolidine-4-carboxylate |
60664-15-5 |
C6H11NO2S |
|
3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile |
2504210-48-2 |
C22H23N9O |
|
Faropenem Impurity D |
|
|
|
[2S-(2alpha,5alpha,6alpha)]-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
24138-28-1 |
C8H10BrNO3S |
|
5-nitro-2-furaldehyde (5-nitrofurfurylene)hydrazone |
736-53-8 |
C10H6N4O6 |
|
4-(benzo[b]thiophen-4-yl)-1,1-bis(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)piperazin-1-ium chloride |
2454317-16-7 |
C38H41N4O4S+ |
|
methyl (R)-thiazolidine-4-carboxylate |
42258-90-2 |
C5H9NO2S |
|
Brivaracetam Impurity 55 |
|
|
|
alpha-(4-chlorophenyl)-alpha-[2-(dimethylamino)ethyl]pyridine-2-acetonitrile |
65676-21-3 |
C17H18ClN3 |
|
Baloxavir Impurity ABCDEFGHJKL |
|
|
|
INDEX NAME NOT YET ASSIGNED |
2514724-36-6 |
C22H19F2N3 |
|
scopoline |
487-27-4 |
C8H13NO2 |
|
N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide |
1474-02-8 |
C21H26N2O |
|
Oseltamivir Impurity 106 |
|
|
|
Oseltamivir Impurity 85 |
|
|
|
Oseltamivir Impurity 83 |
|
|
|
Oseltamivir Impurity 75 |
|
|
|
[1,1'-bicyclohexyl]-1-carboxylic acid |
60263-54-9 |
C13H22O2 |
|
3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- |
2626934-45-8 |
C25H30Cl2N6OS2 |
|
Dapagliflozin Impurity 49 |
|
|
|
11-[3-(dimethylamino)propyl]-6,11-dihydrodibenz[b,e]oxepin-11-ol |
4504-88-5 |
C19H23NO2 |
|
Avatrombopag Impurity ABCDEFGHJKL |
|
|
|
1-(2-chloroethyl)-3-(dicyclopropylmethyl)urea |
54187-03-0 |
C10H17ClN2O |
|
1,3-Dioxane-4-acetic acid, 6-[2-[3-[[[2-[(4R,6R)-6-[2-(1,1-dimethylethoxy)-2-oxoethyl]-2,2-dimethyl-1,3-dioxan-4-yl]ethyl]amino]carbonyl]-5-(4-fluorophenyl)-2-(1-methylethyl)-4-phenyl-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, 1,1-dimethylethyl ester, (4R,6R)- |
1229658-18-7 |
C48H67FN2O9 |
|
1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, 1,1-dimethylethyl ester, (βS,δR)- |
2588261-38-3 |
C37H43FN2O5 |
|
3-hydroxy-2,4-dimethoxybenzaldehyde |
32246-34-7 |
C9H10O4 |
|
butyl 3-aminosulphonyl-5-butylamino-4-phenoxybenzoate |
32643-00-8 |
C21H28N2O5S |
|
11beta,16alpha,17,21-tetrahydroxypregn-4-ene-3,20-dione |
1171-81-9 |
C21H30O6 |
|
trans-2-amino-N-(4-hydroxycyclohexyl)benzamide |
15942-11-7 |
C13H18N2O2 |
|
4-O-(Carboxymethyl)rifamycin |
13929-35-6 |
C39H49NO14 |
|
ethyl 3,5-bis(benzyloxy)benzoate |
50841-46-8 |
C23H22O4 |
|
Revefenacin Impurity 7 |
1158777-54-8 |
C14H19ClN2O3 |
|
(R)-8-(3-aminopiperidin-1-yl)-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione |
|
|
|
Oxytocin Impurity 8 Trifluoroacetate |
|
|
|
Peramivir Dehydrated Impurity |
|
|
|
Apixaban Impurity 78 |
|
|
|
Formoterol Impurity 32 |
|
|
|
(1S,2S,3R,4R)-2-((R)-1-acetamido-2-ethylbutyl)-4-guanidino-3-hydroxycyclopentane-1-carboxylic acid |
|
|
|
Desloratadine EP impurity A hcl |
2250242-44-3 |
C19H21Cl2FN2 |
|
(R)-6-(2-((1S,2S)-2,6-dimethyl-1,2,3,4-tetrahydronaphthalen-1-yl) ethyl)-5,6-dihydro-2H-pyran-2-one and (R)-6-(2-((R)-2,6-dimethyl- 5,6,7,8-tetrahydronaphthalen-1-yl)ethyl)-5,6-dihydro-2H-pyran-2-one |
|
|
|
(3S,4S)-Tofacitinib |
1092578-47-6 |
C16H20N6O |
|
Rosuvastatin Impurity 145 |
|
|
|
NA |
|
|
|
Peramivir Intermediate impurity 1 |
|
|
|
NA |
|
|
|
Peramivir Intermediate Impurity 43 |
|
|
|
Peramivir Deacetylated Impurity |
|
|
|
NA |
|
|
|
Loxoprofen Sodium Impurity 35 |
|
|
|
Dashatinib impurity 46 |
|
|
|
(R,S)-N-Acetyl-3,4-dimethoxy phenylalanine |
27313-65-1 |
C13H17NO5 |
|
Oxytocin oxide impurity reference substance |
|
|
|
Troxipide Impurity 7 |
|
|